The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 277.00
Bid: 274.00
Ask: 280.00
Change: 0.00 (0.00%)
Spread: 6.00 (2.19%)
Open: 277.00
High: 277.00
Low: 274.00
Prev. Close: 277.00
CCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 May 2023 11:32

RNS Number : 7521Z
Character Group PLC
17 May 2023
 

 

17 May 2023

 

 

The Character Group plc

Designers, developers and international distributor of toys, games and giftware

(the "Company")

 

Directors' share dealings

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 

 

The Character Group plc (AIM: CCT), received a notice yesterday (16 May 2023) from Mr Kiran Shah (the Joint-Managing Director of the Company and Group Finance Director) notifying the Company of share transactions effected by him that day. 

 

Mr Shah has disclosed that he has sold 14,605 ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares") at a price of 331p per share and, through his personal ISA account, has purchased 14,605 Ordinary Shares at a price of 331p per share. Following these transactions, Mr Shah's interest in Ordinary Shares remains unchanged at 1,928,766 Ordinary Shares, which represents approximately 9.96% of the Company's issued voting Ordinary Share capital.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Kiran Shah

2.

Reason for the notification

a.

Position/status

Joint Managing Director and Group Finance Director

b.

Initial notification/Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

The Character Group plc

b.

LEI

213800HY6EB8T8VWWE73

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5 pence

 

GB0008976119

b.

Nature of the transaction

Sale and purchase of shares

c.

Price(s) and volume(s)

Price(s)

Volume

331p

14,605

331p

14,605

d.

Aggregated information

· Aggregated volume

· Price

 

14,605 Ordinary Shares (sold) at 331 pence per Ordinary Share

14,605 Ordinary Shares (bought) at 331 pence per Ordinary Share

e.

Date of the transaction

16 May 2023

f.

Place of the transaction

London Stock Exchange, AIM

 

 

ENQUIRIES:

The Character Group plc

Jon Diver, Joint Managing Director

Kiran Shah, Joint Managing Director

Office: +44 (0) 208 329 3377

Mobile: +44 (0) 7831 802219 (JD)

Mobile: +44 (0) 7956 278522 (KS)

Email: info@charactergroup.plc.uk

 

 

Panmure Gordon

(Nominated Adviser and Joint Broker)

Atholl Tweedie, Investment Banking

Rupert Dearden, Corporate Broking

Tel: +44 (0) 20 7886 2500

Allenby Capital Limited

(Joint Broker)

Nick Athanas, Corporate Finance

Amrit Nahal, Sales & Corporate Broking

Tel: +44 (0) 20 3328 5656

 

TooleyStreet Communications Limited

(Investor and media relations)

Fiona Tooley

Tel: +44 (0) 7785 703523

Email: fiona@tooleystreet.com   

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDLFFXELXBBB
Date   Source Headline
26th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20246:16 pmRNSTransaction in Own Shares
11th Apr 20245:23 pmRNSTransaction in Own Shares
9th Apr 20245:25 pmRNSTransaction in Own Shares
8th Apr 20245:49 pmRNSTransaction in Own Shares
4th Apr 20245:44 pmRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSExtension of & increase to Share Buyback Programme
13th Mar 20245:19 pmRNSTransaction in Own Shares
7th Mar 20245:55 pmRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20245:03 pmRNSTransaction in Own Shares
27th Feb 20245:03 pmRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20245:20 pmRNSTransaction in Own Shares
22nd Feb 20245:59 pmRNSTransaction in Own Shares
21st Feb 20245:03 pmRNSTransaction in Own Shares
19th Feb 20246:08 pmRNSTransaction in Own Shares
19th Feb 202412:07 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:13 pmRNSTransaction in Own Shares
14th Feb 20245:38 pmRNSTransaction in Own Shares
13th Feb 20245:49 pmRNSTransaction in Own Shares
9th Feb 20244:19 pmRNSTransaction in Own Shares
8th Feb 20245:44 pmRNSTransaction in Own Shares
7th Feb 202410:20 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSShare Buyback Programme
19th Jan 20244:41 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement - Trading Update
14th Dec 202312:53 pmRNSHolding(s) in Company
14th Dec 202312:49 pmRNSHolding(s) in Company
12th Dec 20237:01 amRNSFinal Results - year ended 31 August 2023
12th Dec 20237:00 amRNSBoard Changes
23rd Oct 20234:58 pmRNSDirector/PDMR Shareholding
3rd Oct 20237:00 amRNSTrading Update
22nd Sep 20234:08 pmRNSHolding(s) in Company
20th Sep 20235:30 pmRNSHolding(s) in Company
22nd Aug 20237:00 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
17th May 202311:32 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSHolding(s) in Company
11th May 20237:00 amRNSHalf-year Report - six months to 28 February 2023
27th Mar 20236:00 pmRNSHolding(s) in Company
20th Jan 20234:41 pmRNSResult of AGM
20th Jan 20237:00 amRNSTrading update ahead of the AGM
28th Dec 20227:34 amRNSDirector's share dealings, Treasury shares and TVR
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
22nd Dec 20227:00 amRNSAUDITED ANNUAL RESULTS -YEAR ENDED 31 AUGUST 2022
21st Oct 20221:41 pmRNSTransfer of treasury shares & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.